30 completed, 13 unknown, 10 recruiting, 8 not yet recruiting. 25 Phase 2, 16 Phase 3, 11 Not applicable, 10 Phase 1, 8 Phase 4.
Follow Minoxidil: new trials by email Literature Review of Minoxidil trials Research Report on Minoxidil
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 3 Study to Evaluate the Efficacy and Safety of Oral Minoxidil (N1087) in Men With Androgenetic Alopecia. Minoxidil oral solution, Placebo oral solution - Androgenetic Alopecia, Androgenetic Alopecia (AGA) | Phase 3 | Not yet recruiting | Eurofarma Laboratorios S.A. | 372 | 2027-01-31 | 2026-04-14 |
| Minoxidil With or Without Low-Level Red-Light Therapy for Improving Chemotherapy-Induced Alopecia in Breast Cancer Patients Electronic Health Record Review, Minoxidil, Revian RED LED-light cap - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | Phase 2 | Not yet recruiting | Ohio State University Comprehensive Cancer Center | 50 | 2026-11-15 | 2026-09-02 |
| Oral Minoxidil With or Without a Multifactorial Drinkable Nutraceutical in Female Pattern Hair Loss: a Retrospective Study Oral low-dose Minoxidil, Drinkable multifactorial food supplement containing vitamins, minerals, plant extracts, and other bioactive compounds, formulated to support hair growth and scalp health in women. - Female Pattern Hair Loss, Female Pattern Hair Loss, Androgenic Alopecia | Not yet recruiting | Olistic Research Labs S.L. | 30 | 2026-10-01 | 2026-10-07 | |
| Comparative Study of Microneedling With Topical Minoxidil 5% ± NB-UVB in Stable Vitiligo" microneedling with minoxidil 5% and NBUVB, Microneedling with Minoxidil5% - Vitiligo - Macular Depigmentation | Phase 2 | Not yet recruiting | Sohag University | 30 | 2026-05-20 | 2026-04-29 |
| VENEZE Peptide Factor Hair Serum Compared With Topical 2% Minoxidil for Androgenetic Alopecia Veneze peptide hair serum, Topical minoxidil - Androgenetic Alopecia (AGA) | Not applicable | Recruiting | Institute of Dermatology, Thailand | 80 | 2026-05-05 | 2026-05-13 |
| Androgenic Alopecia TH07 Clinical Trial TH07, Minoxidil 5% Topical Solution, Placebo - Androgenic Alopecia | Phase 3 | Recruiting | Triple Hair Inc | 420 | 2026-04-01 | 2026-03-16 |
| Assessment of Topical Minoxidil on Intraoperative Flap Perfusion and Cutaneous Flap Viability in Breast Recon Minoxidil, Hair mousse - Breast Reconstruction, Perfusion; Complications | Phase 1 | Recruiting | Duke University | 25 | 2026-03-16 | 2026-07-08 |
| Topical Methotrexate vs Minoxidil for Localized Alopecia Areata Methotrexate 1% Topical Gel, Minoxidil 5% Topical Spray - Alopecia Areata | Phase 4 | Not yet recruiting | Jinnah Postgraduate Medical Centre | 268 | 2026-03-15 | 2026-03-10 |
| JAK2 Expression in Androgenetic Alopecia Before and After Topical Minoxidil Topical Minoxidil 5% Solution, Scalp Punch Biopsy, Tissue JAK2 Protein Measurement by ELISA - Androgenetic Alopecia, Androgenic Alopecia | Not applicable | Recruiting | Kasr El Aini Hospital | 25 | 2026-02-01 | 2026-05-01 |
| Topical Application of Lactobacillus Reuteri for Androgenetic Alopecia Lactobacillus reuteri, Inactivated Lactobacillus reuteri, 5% Minoxidil - Androgenetic Alopecia (AGA) | Phase 2 | Recruiting | Shenzhen People's Hospital | 388 | 2026-01-25 | 2026-04-01 |
| Topical 2-Deoxy-D-ribose Hydrogel Versus Minoxidil 5% Solution for Androgenetic Alopecia Topical 2-Deoxy-D-ribose Hydrogel, Topical Minoxidil 5% Solution - Androgenic Alopecia | Not applicable | Recruiting | Kasr El Aini Hospital | 60 | 2026-01-01 | 2026-04-06 |
| Comparison of Outcomes Between Topical Minoxidil Versus Oral Minoxidil for the Treatment of Androgenetic Alopecia Minoxidil 5 % Topical Spray, minoxidil, Placebo Spray - Androgenic Alopecia | Phase 3 | Not yet recruiting | Sheikh Zayed Federal Postgraduate Medical Institute | 200 | 2025-12-20 | 2025-12-10 |
| Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Androgenic Alopecia Topical Minoxidil, Electric Microneedling, Traditional Exosome Lyophilized Powder - Androgenic Alopecia | Not applicable | Completed | Fujian Medical University Union Hospital | 18 | 2025-11-06 | 2026-09-02 |
| A Study on the Treatment of Androgenetic Alopecia in Young Men With Umbilical Cord Mesenchymal Stem Cell Exosomes Human umbilical cord mesenchymal stem cell exosomes, Minoxidil 5% Topical Solution - Androgenic Alopecia | Phase 1 / Phase 2 | Recruiting | Shenzhen People's Hospital | 59 | 2025-09-20 | 2025-12-02 |
| Efficacy & Safety of Minoxidil SL Tablets in Men With AGA Minoxidil, Placebo - Androgenetic Alopecia, Male Pattern Baldness | Phase 3 | Completed | Samson Clinical Operations Pty Ltd | 142 | 2025-07-14 | 2026-05-18 |
| Low Dose Oral Minoxdil in Androgenic Alopecia 2.5% Oral minoxidil, 1% Oral Minoxidil - Androgenetic Alopecia (AGA) | Not applicable | Not yet recruiting | Jinnah Postgraduate Medical Centre | 76 | 2025-06-15 | 2025-06-12 |
| A Safety and Efficacy Study of PDFE-2304 Topical Solution for the Treatment of Androgenic Alopecia. Minoxidil 5% Topical Solution, PDFE-2304 Topical Solution - Alopecia, Androgenetic, Baldness | Phase 2 | Active not recruiting | PDFE Pharma Innovations FZCO | 15 | 2025-05-14 | 2025-06-08 |
| Various Procedural Treatment Options for Androgenetic Alopecia topical finasteride, Topical minoxidil - Androgenetic Alopecia | Phase 2 | Not yet recruiting | Sheikh Zayed Medical College | 190 | 2025-02-01 | 2025-02-13 |
| Clinical Trial to Evaluate CG2001 in Chinese Adult Male Participants With Androgenetic Alopecia minoxidil + finasteride, Placebo foam - Male Pattern of Hair Loss, Androgenic Alopecia, Androgenetic Alopecia (AGA) | Phase 2 | Completed | Beijing Dayspring Pharmaceutical Technology Co., Ltd | 110 | 2024-12-05 | 2026-03-03 |
| Evaluation of Efficacy and Safety of Oral Minoxidil 1 mg in Female Androgenetic Alopecia Minoxidil Tablets, Minoxidil Topical, Placebo oral tablet - Androgenetic Alopecia, Female Pattern Baldness | Phase 3 | Active not recruiting | Industrial Farmacéutica Cantabria, S.A. | 520 | 2024-10-17 | 2026-09-16 |
Showing 20 of 68. Sign in to see all of them.
Alopecia (51) · Alopecia Areata (2) · Acne Vulgaris (1) · Bulbo-Spinal Atrophy, X-Linked (1) · Carcinoma, Ovarian Epithelial (1) · Cardiovascular Abnormalities (1) · Fissure in Ano (1) · Genetic Predisposition to Disease (1) · Hair Diseases (1) · Hypertension (1) · Hypotrichosis (1) · Ovarian Neoplasms (1) · Skin Diseases (1) · Williams Syndrome (1)
Sohag University (3) · Universitas Indonesia (3) · Allergan (2) · Aneira Pharma, Inc. (2) · Applied Biology, Inc. (2) · Cairo University (2) · Dr. dr. Lili Legiawati, SpKK(K) (2) · Industrial Farmacéutica Cantabria, S.A. (2) · Jinnah Postgraduate Medical Centre (2) · Kasr El Aini Hospital (2) · Ohio State University Comprehensive Cancer Center (2) · Second Affiliated Hospital, Zhejiang University, School of Medicine (2) · Shenzhen People's Hospital (2) · Assiut University (1) · Beijing Dayspring Pharmaceutical Technology Co., Ltd (1)
United States (20) · Egypt (7) · China (6) · Germany (6) · Indonesia (5) · Australia (4) · India (4) · Canada (3) · Italy (3) · Spain (3) · Brazil (2) · France (2) · Pakistan (2) · Taiwan (2) · Thailand (2)
Brittany L Dulmage, MD (2) · Flavio Grasso, MD (2) · Rodney Sinclair, MD (2) · Sharon Keene, MD (2) · Adam P Bress, PharmD, MS (1) · Adhika A Lestari, MD (1) · Alina Markova, MD (1) · Alison Bruce, M.B. Ch.B (1) · Amy J McMichael, MD (1) · Barbara Uzel, M.D (1) · Betsy Hughes-Formella, PhD (1) · Brett Phillips, MD (1)
PMID 10495374, PMID 11511857, PMID 1188424, PMID 15034503, PMID 17569567, PMID 17761356, PMID 19277688, PMID 22440736, PMID 23960389, PMID 25315746, PMID 27391640, PMID 27659896, PMID 30501016, PMID 30886475, PMID 31138170, PMID 31574029, PMID 31823902, PMID 32028023, PMID 32231700, PMID 32346854, PMID 32425997, PMID 33112463, PMID 33891615, PMID 34099599, PMID 35318791, PMID 35492401, PMID 35796224, PMID 35920739, PMID 36257912, PMID 36571611, PMID 37016778, PMID 37166619, PMID 37292551, PMID 37605227, PMID 38598226, PMID 40021536, PMID 40654553, PMID 8326155, PMID 9777765
2009 (1), 2023 (1)